Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_provenance.
- NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_assertion description "[SNPs within the efflux transporter genes ABCC1 (ATP-binding cassette, subfamily C, member 1) and ABCG2 (ATP-binding cassette, subfamily G, member 2) are associated with good response to methotrexate therapy in patients with psoriasis; the former gene was also associated with the onset of toxicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_provenance.
- NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_assertion evidence source_evidence_literature NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_provenance.
- NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_assertion SIO_000772 18256692 NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_provenance.
- NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_assertion wasDerivedFrom gad-20150221 NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_provenance.
- NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_assertion wasGeneratedBy ECO_0000203 NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_provenance.
- gad-20150221 importedOn "2015-02-21" NP118595.RA3SJTZoAJDrOo65i1VlZqt4kxLFLd1VZK4a41SIm_szo130_provenance.